Clinical Trial: Ablation of Hepatocellular Carcinoma: a Nationwide Study
Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Condition:
Hepatocellular Carcinoma
Ablation
Hepatitis C
Study Type: Observational
Official Title: Ablation of Hepatocellular Carcinoma: a Nationwide Study
Brief Summary:
Background Hepatocellular carcinoma (HCC) is the most common primary malignancy in the liver. Chronic infection with hepatitis C virus (HCV) is a significant risk factor and may be associated with inferior outcome. According to the Danish national guidelines, ablation should be offered patients with early HCC (tumor < 3 cm) in a cirrhotic liver, who are not transplant candidates. However, the effect of size of the HCC tumor and Hepatitis C virus (HCV) as etiology are insufficiently investigated.PurposesInvestigate…
Read more